We investigated checkpoint molecule CD72 on B cells, its clinical associations, and dynamic changes upon rituximab (RTX) treatment.<h4>Methods</h4>Thirty SLE patients (26 with active disease) were studied. This evidence concerns the gene CD72 and systemic lupus erythematosus.